SCHEMBL12827353

SCHEMBL12827353

COc1ccc2c(c1)C1(C)CCCC(C)(C)[C@@H]1C2=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRD1 P41143 1/20 0.46
POLA1 P09884 4/20 0.45
CYP3A4 P08684 2/20 0.43
CYP2C9 P11712 1/20 0.43
TSHR P16473 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 1/20 0.42
THRB P10828 1/20 0.42
MAPK1 P28482 1/20 0.42
ACHE P22303 1/20 0.41
PDE7A Q13946 1/20 0.39
METAP1 P53582 1/20 0.39
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
EHMT2 Q96KQ7 1/20 0.38
OPRK1 P41145 3/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12825563 1.00 OPRD1 (0.46) OPRD1POLA1CYP3A4CYP2C9TSHR
SCHEMBL16499555 1.00 OPRD1 (0.46) OPRD1POLA1CYP3A4CYP2C9TSHR
SCHEMBL16499412 1.00 OPRD1 (0.46) OPRD1POLA1CYP3A4CYP2C9TSHR
SCHEMBL12821475 0.84 BACE1 (0.39) OPRD1OPRK1
SCHEMBL16499411 0.84 NR1H2 (0.49) POLA1CYP3A4ALDH1A1ACHEMEN1
SCHEMBL12821620 0.82 GSTP1 (0.41) OPRD1TSHRALDH1A1GAAOPRK1
SCHEMBL16499462 0.81 OPRK1 (0.39) OPRD1TSHRALDH1A1MEN1GAA
SCHEMBL16499381 0.81 HSD11B1 (0.36) OPRD1POLA1OPRK1
SCHEMBL12825569 0.81 OPRK1 (0.39) OPRD1TSHRALDH1A1MEN1GAA
SCHEMBL12825604 0.81 ACHE (0.37) CYP3A4CYP2C19ALDH1A1ACHEMETAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012134971-A2 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS, INC. (US) 2012-10-04 WO disclosed